Ernesto Chavez (CRD: 4315877) faces a new pending claim on BrokerCheck over an investment made in 2018. The customer alleges $180,000 in damages, and no arbitrator has ruled on the claim.
Soreide Law Group is looking into possible investor claims against securities broker Archie Abel Blood Jr. (also known as Bud Blood) (CRD: 1861277, Holland, Michigan). Particularly, FINRA sanctioned the securities broker, who worked for Cambridge Investment Research Inc. Allegedly, Blood engaged in private securities transactions. Here is a brief summary of FINRA’s allegations against Blood.
Evidently, on February 1, 2023, FINRA issued Case: 2021071992801, sanctioning Archie Blood for infractions. Specifically, Blood agreed to pay a $4,000 fine and serve a four-month suspension as a securities broker. Particularly, FINRA alleged that Blood engaged in private securities transactions involving $400,000 in unit purchase agreements.
Have you experienced damages due to the actions of Archie Blood? If you have, then you can contact Soreide Law Group at (888) 760-6552 and speak with a securities lawyer about a possible recovery of your investment losses. Soreide Law Group, who has successfully recovered money for hundreds of investors throughout the United States, represents clients on a contingency fee basis and advances all costs. Please keep in mind that Blood and brokerage firms Blood worked for deny all allegations of sales practice violations.
Ernesto Chavez (CRD: 4315877) faces a new pending claim on BrokerCheck over an investment made in 2018. The customer alleges $180,000 in damages, and no arbitrator has ruled on the claim.
William Tunink (CRD: 2738224) settled a customer claim for $299,000 on August 11, 2026, according to his BrokerCheck report. The customer alleged that he obtained loans from the customer, and that some of the money went into an investment.
Tony Barouti (CRD: 3031995) faces a pending $230,400 customer claim, according to his BrokerCheck report. He says the allegations in it are false. His report also lists SEC administrative and cease-and-desist proceedings from August 2025.
Phone:
Fax: 1-954-760-6553
Email: [email protected]